
Full text loading...
Category: Clinical Microbiology
Central Nervous System Infections, Page 1 of 2
< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555819040/9781555819033_Chap24-1.gif /docserver/preview/fulltext/10.1128/9781555819040/9781555819033_Chap24-2.gifAbstract:
Infections of the central nervous system (CNS) are associated with significant morbidity and mortality, with outcome often dependent on the rapidity with which a pathogen is identified and appropriate therapy is begun. Immunocompromised hosts are at risk for CNS infections with both common microorganisms, which may present atypically in this population, and with opportunistic pathogens. The microbiologic causes of infection vary by syndrome (e.g., meningitis versus encephalitis) and specific impairment in immunity (e.g., deficits in T-cell function versus hypogammaglobulinemia). This chapter provides a framework for the assessment and laboratory evaluation of immunocompromised patients presenting with CNS infections. Detailed discussions of the individual agents are provided in the corresponding pathogen-specific chapters.
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0012-2015Full text loading...
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0012-2015Trypanosoma cruzi meningoencephalitis in a patient with acquired immunodeficiency syndrome. Case published as reference 173 .
Trypanosoma cruzi meningoencephalitis in a patient with acquired immunodeficiency syndrome. Case published as reference 173 .
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0012-2015(A) Trypanosoma cruzi trypomastigote in CSF stained with Giemsa. Image courtesy of CDC Division of Parasitic Diseases and Malaria, DPDx. http://www.cdc.gov/dpdx/trypanosomiasisAmerican/gallery.html#tcruzicsf (B) Trypanosoma cruzi trypomastigote in cerebrospinal fluid (CSF) stained with Giemsa. Image courtesy of CDC Division of Parasitic Diseases and Malaria, DPDx. http://www.cdc.gov/dpdx/trypanosomiasisAmerican/gallery.html#tcruzi
(A) Trypanosoma cruzi trypomastigote in CSF stained with Giemsa. Image courtesy of CDC Division of Parasitic Diseases and Malaria, DPDx. http://www.cdc.gov/dpdx/trypanosomiasisAmerican/gallery.html#tcruzicsf (B) Trypanosoma cruzi trypomastigote in cerebrospinal fluid (CSF) stained with Giemsa. Image courtesy of CDC Division of Parasitic Diseases and Malaria, DPDx. http://www.cdc.gov/dpdx/trypanosomiasisAmerican/gallery.html#tcruzi
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0012-2015Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0012-2015Major infectious causes of meningitis among immunocompromised hosts
Major infectious causes of meningitis among immunocompromised hosts
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0012-2015Major infectious causes of encephalitis or mass lesions of the brain among immunocompromised hosts
Major infectious causes of encephalitis or mass lesions of the brain among immunocompromised hosts
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0012-2015Infectious causes of myelitis among immunocompromised patients
Infectious causes of myelitis among immunocompromised patients
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0012-2015Microbiological methods used for laboratory diagnosis of CNS infections
Microbiological methods used for laboratory diagnosis of CNS infections
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0012-2015